Analysts forecast that Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Rating) will report ($0.48) earnings per share for the current quarter, according to Zacks. Five analysts have issued estimates for Syros Pharmaceuticals’ earnings. The highest EPS estimate is ($0.45) and the lowest is ($0.51). Syros Pharmaceuticals posted earnings per share of ($0.23) in the same quarter […]
Wall Street brokerages expect Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Rating) to announce sales of $4.56 million for the current fiscal quarter, Zacks reports. Five analysts have provided estimates for Syros Pharmaceuticals’ earnings. The lowest sales estimate is $3.10 million and the highest is $5.85 million. Syros Pharmaceuticals reported sales of $4.83 million in the […]
$5 65 Million in Sales Expected for Syros Pharmaceuticals, Inc (NASDAQ:SYRS) This Quarter etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.